title: The predictive safety testing consortium and the coalition against major diseases.
abstract: The Predictive Safety Testing Consortium and the Coalition Against Major Diseases, both launched by the Critical Path Institute, provide valuable examples of the outcomes and lessons learned by different types of consortia working on new drug development tools.
authors.affiliation: Critical Path Institute, 1730 East River Road Tucson, Arizona 85718, USA.
authors.forename: Diane
authors.initials: D
authors.lastname: Stephenson
authors.affiliation: Critical Path Institute, 1730 East River Road Tucson, Arizona 85718, USA.
authors.forename: John-Michael
authors.initials: JM
authors.lastname: Sauer
mesh_terms: D003299:Cooperative Behavior; D019091:Critical Pathways; D004194:Disease; D055808:Drug Discovery / Q000379:methods*; D006801:Humans; D004364:Pharmaceutical Preparations; D012449:Safety
chemical_list: D004364:Pharmaceutical Preparations